Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 34Thoracic 22Genitourinary 15Gastrointestinal 15Dermatologic 14Gynecologic 13Head & Neck 11Sarcoma 4Other solid neoplasm 3Endocrine 2Lymphoid 1CNS 1

Conditions

Brain Neoplasms 33Glioblastoma 32Melanoma 21Glioma 19Neuroblastoma 7Carcinoma, Renal Cell 6Carcinoma, Non-Small-Cell Lung 6Astrocytoma 6Ependymoma 5Colorectal Neoplasms 5Central Nervous System Neoplasms 5Recurrence 4Ovarian Neoplasms 4Medulloblastoma 4Lymphoma 4Carcinoma, Hepatocellular 4Thyroid Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Rhabdomyosarcoma 3Pancreatic Neoplasms 3Osteosarcoma 3Meningioma 3Lung Neoplasms 3Gliosarcoma 3Cholangiocarcinoma 3Carcinoma, Transitional Cell 3Vulvar Neoplasms 2Uterine Cervical Neoplasms 2Stomach Neoplasms 2Small Cell Lung Carcinoma 2

Interventions

pembrolizumab 3Trastuzumab 2Irinotecan 2Cyclophosphamide 2vocimagene amiretrorepvec 1veliparib 1sacituzumab govitecan 1paclitaxel-Angiopep-2 conjugate 1lenvatinib 1irinotecan sucrosofate 1iniparib 1fludarabine 1depatuxizumab mafodotin 1cabozantinib 1bintrafusp alfa protein, human 1aldesleukin 1Platinum 1Nivolumab 1NVP-BKM120 1N-(2,3-dihydroxypropyl)-1-((2-fluoro-4-iodophenyl)amino)isonicotinamide 1Metformin 1Mebendazole 1Ipilimumab 1Interleukin-2 1Flucytosine 1Doxycycline 1Cisplatin 1Capecitabine 1Atorvastatin 17-hydroxystaurosporine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Triple Negative Breast Neoplasms × Nivolumab × CNS × Clear all
NCT04434560 2022-07-26

Neoadjuvant Immunotherapy in Brain Metastases

Duke University

Phase 2 Terminated
1 enrolled 7 charts
BreastCNSDermatologicGenitourinaryGynecologicThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Melanoma, Ovarian Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡